CrossrefInfokarte
Oveporexton: The first-in-class orexin receptor 2 (OX2R) agonist approved for treatment of narcolepsy type 1 (NT1)
Drug Discoveries & Therapeutics · 2026-08-31 · 20 (4) · 357-359
DOI: 10.5582/ddt.2026.01056 ↗Abstract
Kein Abstract verfügbar.
EUVIMED